BLOG
    FAQ
    X
    Visit blog page
    BOTOX® 100u (Polish)  distributors
    BOTOX® 100u (Polish)  distributors
    BOTOX® 100u (Polish)  distributors
    BOTOX® 100u (Polish)  distributors

    Buy BOTOX® 100u (Polish) Online

    (0)

    0

    brand:

    BOTOX®

    origin:

    The origin of this product is Europe

    manufacturer:

    Allergan

    active substances:

    BOTULINUM TOXIN TYPE A

    strength:

    100u

    pack size:

    1 x 100u Vial

    INFORMATION

    Buy More Botulinum Toxin Injection    Buy More Botox Products

    BOTOX® 100u, known scientifically as onabotulinumtoxinA, is a sterile, vacuum-dried purified botulinum toxin type A product intended for intramuscular use. This neurotoxin is produced from the fermentation of the Hall strain Clostridium botulinum and is specifically designed for cosmetic and medical treatments.

    • Product Composition:
      • Each vial contains either 50 Units or 100 Units of Clostridium botulinum type A neurotoxin complex.
      • Contains 0.25 mg of Albumin Human and 0.45 mg of sodium chloride in the 50 Unit vial.
      • Contains 0.5 mg of Albumin Human and 0.9 mg of sodium chloride in the 100 Unit vial.
      • The product is vacuum-dried and does not contain preservatives.

    BOTOX® 100u Mechanism of Action

    BOTOX® Cosmetic operates by blocking neuromuscular transmission. It binds to acceptor sites on motor nerve terminals, enters the nerve terminals, and inhibits the release of acetylcholine, a neurotransmitter critical for muscle contraction.

    • Action Mechanism:
      • The toxin cleaves SNAP-25, a presynaptic protein necessary for the docking and release of acetylcholine.
      • This results in partial chemical denervation of the muscle, causing reduced muscle activity, which may lead to muscle atrophy and potentially the development of new acetylcholine receptors.

    BOTOX® 100u Clinical Pharmacology and Efficacy

    BOTOX® 100u is effective for treating various conditions related to muscle overactivity. Its effects can be observed as early as one to two days post-injection, with the intensity of the effect peaking within the first week.

    • Pharmacodynamics:
      • No formal pharmacodynamic studies have been conducted for BOTOX® Cosmetic.
      • Using the current technology, the presence of BOTOX® in the bloodstream after intramuscular injection at recommended doses is undetectable.

    BOTOX® 100u Dosage and Administration

    The product’s administration is crucial for its safety and efficacy. It requires accurate dosing, proper storage, and an understanding of the patient’s anatomy.

    • Safe Use Instructions:
      • Max cumulative dose: Should not exceed 400 Units in a three-month interval when used for multiple indications.
      • Reconstitute BOTOX® Cosmetic with 0.9% preservative-free sodium chloride.
      • Typical dosage for glabellar lines is 20 Units (0.1 mL at each of the 5 injection sites).

    BOTOX® 100u Contraindications and Precautions

    BOTOX® Cosmetic is contraindicated in patients with a known hypersensitivity to botulinum toxin or any of the components in the formulation. It is also contraindicated in patients with infections at the proposed injection sites.

    • Key Warnings:
      • Spread of Toxin Effects: BOTOX® may spread beyond the injection site, causing symptoms consistent with botulinum toxin effects, such as muscle weakness and breathing difficulties.
      • Cardiovascular Risks: The product has been associated with adverse reactions in the cardiovascular system, some of which were fatal.

    Adverse Reactions

    Adverse reactions to BOTOX® Cosmetic can vary based on the treated area. Common side effects include eyelid ptosis (3%) for glabellar lines and headache (9%) for forehead lines.

    • Other Reactions:
      • Lateral canthal lines: Eyelid edema (1%).
      • Glabellar lines: Brow ptosis (2%).

    Overdosage

    Overdosage of BOTOX® Cosmetic can lead to neuromuscular weakness, potentially requiring hospitalization. In severe cases, paralysis of respiratory muscles may necessitate mechanical ventilation.

    • Immediate Actions:
      • Symptoms may not present immediately.
      • Monitor patients for several weeks for systemic muscle weakness.
      • In case of overdose, an antitoxin is available from the CDC but will not reverse effects already apparent.

    BOTOX® 100u Use in Specific Populations

    BOTOX® Cosmetic’s safety and efficacy have not been established in pediatric patients or pregnant women. Use with caution in geriatric patients, especially for treating facial lines.

    • Pregnancy:
      • No adverse effects were observed in fetal development during studies with pregnant rats.
      • There is no data on the presence of BOTOX® in human or animal milk.

    BOTOX® 100u Storage and Handling

    Unopened vials should be stored in a refrigerator at 2° to 8°C. Reconstituted BOTOX® should be stored similarly and used within 24 hours. The product labeling includes tamper-evident seals and holographic films to ensure authenticity.

    This comprehensive summary integrates essential details about BOTOX® 100u, focusing on its composition, mechanism of action, dosage, and safety considerations. By adhering to these guidelines, healthcare providers can maximize the therapeutic benefits of BOTOX® while minimizing risks to patients.

    Product Substitutes

    Check out these alternatives that might suit your needs

    View more alternatives from Botulinum Toxins chevron-right
    Related Products
    Shopping Bag0
    There are no products in the cart!